| NCT06546995 | Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease | RECRUITING | PHASE1 | 2024-07-09 | 2025-11 | 2025-11 |
| NCT06429722 | To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder. | COMPLETED | PHASE2 | 2024-05-13 | 2025-05-30 | 2025-04-09 |
| NCT06058039 | Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder | RECRUITING | PHASE3 | 2023-12-21 | 2026-03 | 2026-02 |
| NCT06058013 | Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder | RECRUITING | PHASE3 | 2023-12-20 | 2026-06 | 2026-05 |
| NCT06029439 | Study to Assess the Safety and Effectiveness of NMRA-335140-501 | RECRUITING | PHASE3 | 2023-11-10 | 2027-06 | 2027-06 |
| NCT06029426 | Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder | COMPLETED | PHASE3 | 2023-09-20 | 2025-01-15 | 2024-12-03 |
| NCT04221230 | Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo | COMPLETED | PHASE2 | 2020-01-03 | 2022-06-23 | 2022-04-08 |